MedPath

Multicenter study about an effect of Vinorelbine for recurrent brteast cancer

Phase 2
Conditions
breast cancer
Registration Number
JPRN-UMIN000002491
Lead Sponsor
Tokushima University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

poor prognoses and poor PS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
tumor size
Secondary Outcome Measures
NameTimeMethod
side effect
© Copyright 2025. All Rights Reserved by MedPath